The CpG dinucleotide is present at -20% of its expected frequency in vertebrate genomes, a deficiency thought due to a high mutation rate from the methylated form of CpG to TpG and CpA. We examine the hypothesis that the 20% frequency represents an equilibrium between rate of creation of new CpGs and accelerated rate of CpG loss from methylation. Using this model, we calculate the expected reduction in the equilibrium frequency of the CpG dinucleotide and find that the observed CpG deficiency can be explained by mutation from methylated CpG to TpG/CpA at -12 times the normal transition rate, the exact rate depending on the ratio of transitions to transversions. The observed rate of CpG dinucleotide loss in a human a-globin nonprocessed pseudogene, Weal, and the apparent replenishment of the CpG pool in this sequence by new mutations, agree with the above parameters. These calculations indicate that it would take 25 million years or less, a small fraction of the time for vertebrate evolution, for CpG frequency to be reduced from undepleted levels to the current depleted levels.
It is generally accepted that methylcytosine mutates at a high rate to thymine (1, 2) . Because methylcytosine in vertebrate DNA exists primarily in the dinucleotide CpG, the net result is an increase of the dinucleotide TpG and its complementary pair CpA (3) . It is this mechanism that is held responsible for the observed deficiency ofthe CpG dinucleotide in vertebrate genomes (4, 5) . This supposition is sustained by the observation that the extent of CpG deficiency and of the corresponding TpG/CpA excess is proportional to the level of DNA methylation in a variety of animals (3) . The correlation can also be seen within the mammalian genome, where the small fraction of DNA that escapes methylation (the so-called "CpG island" fraction) fails to show any CpG deficiency (6) (7) (8) . When a CpG island becomes methylated, however, as has happened at a pseudogene in the human a-globin region, CpGs are lost to TpG/CpA at a comparatively high rate (9) . The instability of methylated CpG is directly evident from the preferential detection of restriction fragment length polymorphisms with enzymes that recognize CpG (10) and from the frequency with which CpG -+ TpG/CpA transitions are responsible for human genetic disorders (11) .
Continued unidirectional mutation, in the absence of selection against genetic changes, might be expected to lead eventually to the complete depletion ofthe CpG dinucleotide. From this viewpoint the level of CpG in the genome has steadily declined since ancestral genomes first became heavily methylated, and a still lower CpG frequency is ultimately to be expected (12) . An alternative view, which we examine here, is that the present CpG deficiency represents an equilibrium state. This model takes into account the fact that mutation continually leads to the production of the CpG dinucleotide and should, therefore, generate a balance between rapid rate of CpG loss and rate of CpG creation. Equilibrium would also occur were loss of the CpG dinucleotide by mutation opposed by natural selection. In this paper we have ignored the possible involvement of selection and have concentrated instead on the hypothesis that the observed frequency of CpG is at an equilibrium determined by opposing mutation forces. We show that this hypothesis can provide an adequate explanation for the observed distribution of CpG. Furthermore, we find that the sequence of the a-globin pseudogene provides direct evidence for an equilibrium of this kind. THEORY A Simple Prediction for a Mutation Balance. The basic theory of a balance of mutation rates is well known (e.g., ref. 13, p. 263) . We assume that the dinucleotide CpG is present at frequency q and mutates to other dinucleotides at rate U. The overall frequency ofother dinucleotides is p = 1 -q, and the mean rate of mutation to CpG is V among these dinucleotides. Then [2] The Rate of Approach to Equilibrium Under a More General Model. It is not necessary to assume that all dinucleotides other than CpG are present at equal frequency. The elevated mutation rate from CpG implies some inequalities amongst the frequencies of the different dinucleotides. These may be calculated as follows.
As previously, we assume that the mutation rate from CpG to TpG and to CpA is u. This mutation rate may be equated to the substitution rate, assuming that the neutral model holds. The calculation is made slightly more general by assuming different transition and transversion rates. We take the mutation rate for transitions as v, and the mutation rate for transversions as w. These mutation rates are pergeneration rates. However, with little error, the relative rates, either of mutation or of substitution, can be taken summed over some reasonably long time period (measured in years). The error involved is small, provided that the time period chosen is sufficiently short that more than one substitution is unlikely to occur per dinucleotide.
The expected frequencies of all 16 dinucleotides are given by a set of 16 recurrence equations. This may be expressed as follows: f' = Mf, where M is a matrix of mutation rates as shown in Table 1 , f is the vector of frequencies of the 16 dinucleotides at some time period, andf' is the corresponding vector at the next time period.
Iteration of the equations'of Table 1 leads to convergence to an equilibrium solution. The equilibrium may be found by Proc. Natl. Acad. Sci. USA 87 (1990) 4693 solving the equationf = Mf. This leads to a straightforward set of solutions, summarized in the first column of Table 2 . The symmetries of the mutation matrix means that the 16 x 16 matrix can, in fact, be reduced to a 6 x 6 matrix, from which the equilibrium solution may be more easily obtained.
The equilibrium values of Table 2 enable the approximate solution of the previous section to be tested. We denote the equilibrium frequency of CpG as q, as previously, so that from line 1 of Table 2,   1 =--E(3 + 7S), 16 [3] where E is defined in Table 2 in terms of R, the ratio of CpG mutations to other transitions, and S, the ratio of transversions to transitions.
To make the formulation comparable with the first calculation, with equal transition and transversion rates, we set S = 1. Substituting for E from Table 2 in Eq. 3 gives the following:
16(22 + 1OR) 11 + 5R Setting R = u/v, this equation is seen to be identical to Eq. 2. Eq. 2 was derived under the assumption of equality of all dinucleotides; this assumption is clearly not a necessary one for deriving the equilibrium. In exploring numerical solutions, we have found it more useful to reverse the direction of the calculation. We regard S and q as fixed and calculate the corresponding value of R. Thus Table 3 shows the required CpG mutation rate necessary to account for particular transversion/transition rates and various possible CpG equilibrium frequencies, expressed as a fraction of the constituent nucleotides. For example, if CpG is present at 20% of its expected value, mutations from CpG need to occur at around [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] times the rate of other transitions. This figure depends on S, the transversion/ transition rate. Bulmer (15) estimates from the rate of evolution in pseudogenes that transversions occur about half as often as transitions. We have used the value ofR corresponding to S = 0.5 to give numerical values in Table 2 for the expected frequencies of all 16 dinucleotides, both raw frequencies and frequencies expressed as a fraction of the constituent nucleotides. (Table 1) and an equivalent matrix for evolution within the al-globin line, in which CpG is assumed to mutate to TpG and CpA at the transitional rate v. The reversibility of the latter matrix allows us to compare the gene and pseudogene sequences directly, rather than having to construct an ancestral sequence. This simplification is similar to that used by Felsenstein (17) in calculating maximum likelihood probabilities of phylogenies. Fig. 1 shows the observed dinucleotides (back row) in the pseudogene sequence, for those dinucleotides classified as CpG in the al sequence. Shown against these are the expected values at various times. The expectation is based on the parameters v = 0.002, w = 0.001, u = 0.0246, chosen from Table 3 to give rise to a 20% equilibrium frequency for the CpG dinucleotide. Dinucleotides having the same expectation (Table 2) are grouped, and their observed values are averaged in Fig. 1 . Absolute values of the time units are not important for the argument. However, if we accept the value of 5 x 10-9 per year given by Li et al. (18) as the neutral mutation rate and equate this to the transition rate, v, then the parameters given above are appropriate for a time unit of -0.002/(5 x 10-) = 0.4 million years.
Looking at the CpG dinucleotide, it can be seen that the expectation starts off at unity (by definition) and decreases over time, the expectation becoming equal to the observed proportion at some time around 64 time units-i.e., 25 Some approximation must be involved in the x2 test because it assumes that each dinucleotide change is a separate event. Each mutational event, in fact, causes changes in two neighboring dinucleotides. Further, the calculation of a minimum x2 value with a choice of expectations from all possible time intervals implies some reduction in the number of degrees of freedom. To test the validity of the x2 test, we therefore used a Monte Carlo simulation to generate artificial Pa sequences starting with the observed al-globin sequence and with the transition probabilities given by the same estimated mutation parameters v = 0.002, w = 0.001, u = 0.0246. The x2 analysis was then applied to the generated data. Generating and analyzing 1000 sequences in this way showed that the x2 value is elevated beyond random expectations. The mean value of x2 was 265.5 with a SD of 28.6, compared with an expected value close to the number of degrees of freedom-i.e., 240. The observed value of x2, 234.0, lies at the low end of the range, thereby confirming the agreement of the observed sequence with expectation under the mutation model.
Observed CpG Mutations at the Factor IX Locus. The replacement of methylated CpG with TpG/CpA in the gene pool requires several steps. Deamination initially gives rise to a mismatched TUG pair, which could, in principle, be repaired to either a COG or a TEA pair. In practice, the repair of T-G mismatches is heavily biased in favor of restoring the original COG (19) , and as a result most methyl-CpG deaminations will not give rise to mutations. Some, however, escape repair and must spread within the population ifthey are to become fixed. If they are selectively neutral, then the substitution rate is expected to be the same as the mutation rate. Because the bulk of genomic DNA is not transcribed into RNA and evolves rapidly in sequence, the assumption that most CpG mutations are, indeed, selectively neutral (as, for example, in the a-globin pseudogene) seems reasonable. On the other hand, CpG mutations in the protein-coding portion of the genome can clearly be deleterious. Cooper 
